Acanthamoeba infection, caused by the free-living amoeba Acanthamoeba, is a rare but potentially severe condition that primarily affects the eyes, skin, and central nervous system. Ocular Acanthamoeba keratitis is the most common manifestation, often associated with contact lens use and poor hygiene practices. The amoeba can invade the cornea, leading to painful symptoms such as eye redness, photophobia, and blurred vision. Prompt diagnosis is challenging, requiring specialized laboratory techniques, and treatment involves aggressive antimicrobial therapy. In severe cases, corneal transplantation may be necessary to restore vision. Beyond ocular involvement, Acanthamoeba can cause cutaneous infections, particularly in individuals with compromised immune systems or open skin wounds. These infections may manifest as painful skin lesions and ulcers. Additionally, Acanthamoeba granulomatous encephalitis (GAE) can occur in immunocompromised individuals, leading to severe neurological symptoms and a high mortality rate. Diagnosis of GAE is often post-mortem due to its rapid and fatal progression.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain